SalesTrax.com Research: Forest Laboratories

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.


Pharmaceutical Business Review

2009-07-13 04:03
Forest Laboratories, Lundbeck Sign Settlement Agreement With Sun, Caraco
Forest, Lundbeck to provide licenses to Caraco for any patents related to LEXAPRO

2009-06-23 04:03
Forest Laboratories' Positive Results From Two Phase-III Trials Of Ceftaroline
Ceftaroline is intended for the treatment of community-acquired bacterial pneumonia (CABP)

2009-06-02 04:03
Ironwood, Forest's Additional Analysis Reveals Expected Outcome
Ironwood and Forest Laboratories have announced positive results from additional analysis of their phase II(b) study assessing the safety and efficacy of the new, first in class agent linaclotide, in 419 patients with irritable bowel syndrome with constipation (IBS-C).